|
|
||||||||


* Department of Food Science, and
Department of Animal Health, Welfare and Nutrition, Faculty of Agricultural Sciences, University of Aarhus, Research Centre Foulum, PO Box 50, DK-8830 Tjele, Denmark
1 Corresponding author: lars.wiking{at}agrsci.dk
| ABSTRACT |
|---|
|
|
|---|
Key Words: milk fat zinc free fatty acid milk fat globule
| INTRODUCTION |
|---|
|
|
|---|
The disadvantage of feeding saturated lipid supplement is that it may impair the milk quality in terms of increased concentration of FFA (Astrup et al., 1980; Wiking et al., 2003, 2005). Earlier studies have shown that feeding high levels of saturated lipid supplements to dairy cows results in milk containing large milk fat globules (MFG; volume-based average diameter) (Wiking et al., 2003, 2004). These large MFG are less stable against pumping of milk, which results in greater concentrations of FFA in the milk (Wiking et al., 2003, 2005), associated with rancid flavor. Additionally, a study has indicated that supplementary dietary Zn might reduce the formation of FFA in milk (Hermansen et al., 1995).
Zinc is the trace element in milk that is present in the largest concentration and the literature reports average values from 3.5 to 4 mg/kg (Johnson, 1974; Anderson, 1992) for normal dairy cows. Zinc is generally considered to be a stabilizing agent of biological membranes (Chvapil, 1976; Lindén et al., 2004). In milk, Zn is found in the milk fat globule membrane (MFGM; Mulder and Walstra, 1974), presumably partly as a cofactor for intrinsic membrane enzymes and partly believed to stabilize the membrane integrity.
The aim of the present study was to examine the effect of low or high de novo milk fat synthesis combined with a high or moderate level of dietary Zn on MFG size and stability. Furthermore, we intended to elucidate the effect of dietary Zn on membrane integrity; in this instance, the mammary glands resistance toward mastitis pathogens and inflammation of the mammary tissue. The study was performed as a 4 x 4 Latin square design with 16 Holstein cows, 2 feeding rations expected to induce low or high de novo milk fat synthesis, and a high or moderate level of dietary Zn.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Determination of the Particle Size Distribution of MFG
Particle size distribution of MFG was determined by laser light scattering as described previously by Wiking et al. (2003). The volume-weighted diameter, d(4,3) (µm), was calculated by the integrated software. This diameter was chosen instead of the surface-weighted diameter, d(3,2), because volume-weighted diameter gives the best correlation to the fat content of milk (Wiking et al., 2004; Michalski et al., 2005).
Analysis of FFA in Milk
The concentration of FFA was analyzed immediately after milking (0 h) and another sample was incubated at 4°C for 28 h after milking. Free fatty acids concentration was analyzed by the Auto Analyzer II method (Lindqvist et al., 1975). The method is based on an extraction of the milk sample with an extraction and lipolytic inhibiting solution containing 2-propanol, heptane, and 1 N H2SO4. In this method, the lipoprotein lipase (present in the aqueous phase) and the lipid are separated. In the auto-analyzer, the solution is mixed with the indicator reagent (phenol red, sodium barbital, and ethanol) and finally the absorbance is recorded at 560 nm in a colorimeter. The results are expressed in milliequivalents per one hundred grams of fat.
Zinc in Feeds, Milk, and Blood
Milk and feed samples were incinerated at 450°C and the ash solubilized in dilute nitric acid before analysis, whereas plasma samples were decomposed in a mixture of concentrated nitric acid and perchloric acid at 200°C. The content of Zn was determined by atomic absorption spectrophotometry (Phillips SP9, Eindhoven, the Netherlands).
Analytical Procedures for Lipid Metabolic Activity in Milk
Milk samples were pipetted, diluted, and distributed to different analyses using a Biomek 2000 Laboratory Automation Workstation (Beckman Coulter, Fullerton, CA). Reagents for N-acetyl-β-D-glucosaminidase (NA-Gase), lactate dehydrogenase (LDH), alkaline phosphatase (AP), and BHBA assays were added in the robotic system as well as in the spectrophotometer/fluorometer Fluostar (BMG Labtechnologies, Offenburg, Germany). Analyses were performed in 96-well plates.
NAGase Activity.
N-Acetyl-β-D-glucosaminidase (EC 3.2.1.30) was determined by a kinetic fluorometric assay, according to Kitchen et al. (1978) and Schüttel (1999); however, the composition of reagents and incubation times were slightly altered. Samples were incubated for 18 min in 37°C with citrate buffer, pH 4.6, and substrate 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide (Sigma, St Louis, MO). The hydrolysis was stopped by a Tritiplex glycine buffer (Merck, Darmstadt, Germany), pH 10.8; emission of 460 nm monochromatic light was measured after excitation with 355 nm light. Standards and controls were placed on every plate in duplicate. The accuracy (relative bias) was 3.9% (low) and 1.8% (high). Intraassay precision was 2.6 and 2.4 (coefficient of variation, CV%), respectively, and interassay precision was 11.2 and 4.6 (CV%), respectively, for low and high controls.
LDH Activity.
Lactate dehydrogenase (EC 1.1.1.27) was analyzed according to Larsen (2005). Standards and controls were placed on every plate in duplicate. The accuracy (relative bias) obtained in the present material was 2.7% (low) and 4.9% (high). Intraassay precision was 8.6 and 3.7 (CV%), respectively, and interassay precision was 15.8 and 10.4 (CV%), respectively, for low and high controls.
AP Activity.
Alkaline phosphatase (EC 3.1.3.1) was determined using fluorometry. The substrate, 4-methylumbelliferone phosphate, was incubated with the sample for 6 min in a diethanolamine buffer, pH 10.0. The reaction was stopped using a Tritiplex III glycine buffer, pH 10.8, and the resulting fluorescence (emission wavelength 460 nm) was measured after excitation with 355 nm monochromatic light. Standard curves were prepared on 4-methylumbelliferone in milk subjected to the same conditions. Standards and controls were placed on every plate in duplicate. The accuracy (relative bias) was 1.3% (low) and 4.4% (high). Intraassay precision was 4.8 and 2.7 (CV%), respectively, and interassay precision was 17.2 and 4.7 (CV%), respectively, for low and high controls.
BHBA.
β-Hydroxybutyrate was analyzed using the enzymatic oxidation of the metabolite. A coupled reaction was determination by fluorometry. The method is described by Larsen and Nielsen (2005). Within-plate precision was 3.0 and 5.6% (CV) and between-plate precision was 8.4 and 6.7%, respectively, for low and high control samples.
Analytical Procedures of Lipid Metabolic Activity in Blood
Blood plasma NEFA were determined using the NEFA C acyl-CoA synthetase–acyl-CoA oxidase assay method (Wako Chemicals GmbH, Neuss, Germany). This NEFA analysis was able to detect plasma FFA larger than C5 (Johnson and Peters, 1993).
β-Hydroxybutyrate was determined spectrophotometrically as an increase in absorbance at 340 nm due to the production of NADH, at slightly alkaline pH in the presence of β-OH-butyrate dehydrogenase. Sample blank was included. The method involved oxamic acid in the media to inhibit lactate dehydrogenase as proposed by Harano et al. (1985).
Alkaline phosphatase activity was determined according to standard methods (Bayer Healthcare, Tarrytown, NY).
Isocitrate dehydrogenase [ICDH, NADP+ oxidoreductase (decarboxylating); EC 1.1.1.42] activity was determined as an increase in absorbance due to oxidation of isocitrate to 2-oxoglutamate.
Malate dehydrogenase (MDH, NAD+ oxidoreductase; EC 1.1.1.37) activity was determined as an increase in absorbance due to oxidation of malate to oxaloacetate and NADH + H+.
All blood analyses were performed using an ADVIA 1650 Chemistry System autoanalyzer (Bayer Corporation, Tarrytown, NY). Intraassay variation (CV%), interassay variation (CV%), and relative bias (% deviation from ideal value) was, in all instances, below the following values: NEFA: 0.9, 5.0, and 2.2; BHBA: 0.7, 2.6, and –0.9; AP: 2.6, 2.7, and –3.6; ICDH: 0.9 and 2.1 (no value for bias); and MDH: 0.7 and 2.0 (no value for bias).
Fatty acid composition of the milk fat was determined by GC separation and quantification as described by Wiking et al. (2003).
Statistical Analyses
The effect of Zn and fat supplement was analyzed using the PROC GLM procedure (SAS Institute, Cary, NC):
![]() |
where Yijkl = dependent variable; µ = overall mean; Fi = effect of feed ration (i = high de novo, low de novo); Znj = the effect of Zn supplements (j = +, –); F x Znij = interactions between the 2 variables; and
ijkl = residual error. P < 0.05 was used as the significant threshold.
| RESULTS |
|---|
|
|
|---|
|
|
Table 3
shows that the FA composition in milk was affected (P < 0.001) by the diet. The low de novo diet resulted in milk with relatively greater proportions of C18 and C18:1 and lower proportions of C6 to 14 and C16. The level of dietary Zn did not affect FA composition.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The ration fed and the use of saturated lipid supplement was not expected to induce milk fat depression, and the milk fat concentration obtained in the present study confirmed that there was no milk fat depression as defined by Bauman and Griinari (2001). Although de novo milk fat synthesis might be reduced by high levels of long-chain FA deriving from feed on the low de novo diet, it is noteworthy that an equally high milk fat yield could be obtained on the high de novo diet with a relatively low dietary FA content.
The present decrease in milk protein percentage when feeding saturated lipid supplements is comparable to results of other studies (Hermansen, 1989; Chilliard, 1993). The decrease is often explained as a dilution of a constant protein production, resulting in increased milk production, and this also seems to be the case in the present study, because the protein yields did not differ between treatments.
Activities of NAGase and LDH in milk are well-documented indicators of bovine mastitis (e.g., Chagunda et al., 2006). The levels of enzyme activity in the present material do not support any speculation of infected or inflamed udders that in any way could affect the present composition or quantity of milk. On the contrary, the range of the enzyme activities measured in the milk throughout the experiment clearly signals healthy glands and animals. The present study furthermore tends to reject the idea that additional dietary Zn would improve the stability of the gland tissue membranes. However, the inherent health level of the cows participating in the present study was high.
Both MDH and ICDH enzymes are involved in producing the reducing equivalents NADH and NADPH, respectively. Both enzymes appear in all tissues in the cytoplasmic phase as well as inside the mitochondria. In particular, ICDH might be of specific importance in cows producing milk because ICDH activity is especially abundant in mammary glands of cows, and this enzyme is believed to deliver a considerable amount of the energy used in elongation of milk FA during de novo synthesis (Bauman et al., 1970). Generally, the ICDH activity in the gland is found to be positively correlated with milk production (Waldschmidt and Rilling, 1973), which is in accordance with the present circumstances. However, in the present study, no difference in ICDH activity was observed in blood plasma between cows because of feeding strategies, indicating that blood ICDH activity is not reflecting mammary tissue activity in this instance.
The obtained difference between the FA composition of milk fat from cows fed the low or high de novo diets was as expected and similar to an earlier study in which fat supplements rich in C16 and C18 were used (Wiking et al., 2003). In that earlier study we observed a slight increase in the proportion of C16 when using saturated fat supplement in contrast to the significant decrease in concentration of C16 found in the present study. Because C16 in milk is synthesized both de novo and directly from the feed, the result can vary depending upon the dietary fat supplement.
The increased average diameter of MFG in milk from cows fed the low de novo diet is in agreement with results obtained by Wiking et al. (2003, 2005). However, in the present study the fat percentage was not greater in milk from cows offered the low de novo diet. It has formerly been shown that increasing fat yield results in increasing average diameter of MFG (Wiking et al., 2004). Furthermore, the concentration of C16, C18, and C18:1 correlates positively with average diameter of the MFG (Wiking et al., 2004), and the high proportion of these FA in milk from the low de novo diet observed in the present study could explain the significantly greater average diameter of MFG. Altogether, this confirms that MFG size increases as the proportion of de novo synthesized milk FA decreases. The explanation could be that saturated milk lipids (C16 and C18) crystallize and therefore have a greater volume than liquid fat.
The level of Zn in the feed varied markedly in the experimental diets. However, this did not affect the concentration of Zn in plasma and milk. On the contrary, the low de novo diet rendered significantly greater concentrations of Zn in plasma and milk than the high de novo diet. Sol Morales et al. (2000) observed that the concentration of Zn and copper in plasma was lower in cows fed soybeans compared with tallow. This indicates that the degree of saturation of the fat source affects the concentration of Zn in plasma and thus in milk. Hermansen et al. (1995) found that feeding a high concentration of Zn only tended to increase the concentration of Zn in whole milk but significantly increased the concentration in the cream fraction. The concentrations of Zn in milk and plasma found in our study are within the range of other studies (Anderson, 1992; Sol Morales et al., 2000; NRC, 2001). To our knowledge, the present study is the first to indicate that the plasma and milk Zn levels are increased by saturated lipid in the diet, and thereby that dietary fat might facilitate the transfer of dietary Zn into plasma and milk.
It was expected that dietary Zn would decrease the accumulation of FFA in milk, as indicated in an earlier study (Hermansen et al., 1995). However, the present study did not confirm that dietary Zn affects lipolysis in milk. Furthermore, the current study indicates that the use of fat supplement has no effect on spontaneous lipolysis under the present circumstances. Formerly it was demonstrated that high levels of saturated fat supplements increase lipolysis in the produced milk during pumping (Wiking et al., 2003, 2005). In the earlier cited studies, the levels of saturated fat supplements were greater and the fat was given as FFA, in contrast to the present study, in which the fat was given as triglycerides, because this should affect the rumen bacteria to a lesser degree. Furthermore, in the present we only focus on spontaneous liposysis. The earlier studies have examined induced lipolysis (i.e., pumping), in which the size of the MFG had a greater impact because of the increased coalescence energy between globules and lower surface tension (Wiking et al., 2003, 2005)
Alkaline phosphatase is a well-recognized enzyme in cows milk. Its activity and distribution have been the object of several investigations (e.g., Kitchen et al., 1970; Kitchen, 1974). The activity is known to be present in the skim milk fraction as well as in the cream fraction, often connected to membrane material (Kitchen, 1974; Fransson and Lönnerdal, 1984). Furthermore, AP is a well known metalloprotein, dependent upon Zn for its catalytic function, requiring several Zn ions per functional unit of enzyme. The present study, however, revealed an inverse relationship between Zn content and AP activity in milk, indicating that the Zn content is not limiting for the AP activity in milk under the present circumstances. However, AP activity in milk seems to be positively correlated to milk fat membrane material, because the high de novo diet both show greater AP activity and smaller volume-weighted diameter of fat globules; that is, more membrane material per volume of fat.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication September 24, 2007. Accepted for publication December 11, 2007.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. J. E. van Hulzen, R. C. Sprong, R. van der Meer, and J. A. M. van Arendonk Genetic and nongenetic variation in concentration of selenium, calcium, potassium, zinc, magnesium, and phosphorus in milk of Dutch Holstein-Friesian cows J Dairy Sci, November 1, 2009; 92(11): 5754 - 5759. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |